NIH supports investigator-initiated observational or biomarker validation studies requiring prospective collection or continued analysis of data or biospecimens; clinical trials are not allowed.
Funder: National Institutes of Health
Due Dates: November 5, 2026 (Renewal/resubmission/revision) | February 5, 2027 (New) | March 5, 2027 (Renewal/resubmission/revision) | June 5, 2027 (New) | July 5, 2027 (Renewal/resubmission/revision) | October 5, 2027 (New) | November 5, 2027 (Renewal/resubmission/revision) | February 5, 2028 (New) | March 5, 2028 (Renewal/resubmission/revision) | June 5, 2028 (New) | July 5, 2028 (Renewal/resubmission/revision) | October 5, 2028 (New) | November 5, 2028 (Renewal/resubmission/revision) | February 5, 2029 (New) | March 5, 2029 (Renewal/resubmission/revision) | June 5, 2029 (New) | July 5, 2029 (Renewal/resubmission/revision)
Funding Amounts: Up to $500,000 in direct costs annually for up to five years
Summary: Supports investigator-initiated observational or biomarker validation studies advancing dental, oral, and craniofacial health.
Key Information: Clinical trials and biomarker discovery projects are not allowed; foreign organizations and foreign components are ineligible.
The National Institute of Dental and Craniofacial Research (NIDCR) supports investigator-initiated observational studies and advanced biomarker validation through the U01 cooperative agreement mechanism. Projects may prospectively collect data or biospecimens, or continue analyzing previously collected materials. The program seeks rigorous, reproducible findings that improve understanding, prevention, diagnosis, and treatment of dental, oral, and craniofacial diseases and disorders.
Supported approaches include population-based and multisite observational studies, longitudinal cohorts, non-interventional comparative effectiveness research, and follow-up after completed clinical trials. Biomarker studies may establish analytical reliability or validate clinical utility in an independent cohort. Priorities include appropriate study design, rigorous exposure and outcome assessment, feasible recruitment and retention, standardized biospecimen methods, and collaboration with experienced statisticians and data managers.